reference/28911633

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28911633

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	104
issn	0028-3908
issueIdentifier	1-2
pageRange	95-104
publicationName	Neuropharmacology
startingPage	95
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0c9844bbdee9205c4154baa99844748d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_efedaa84bffcc633bdce6e01cce7e10c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6c326fc7cdeb321b3c8a50653d24949c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1436482bea9e87a44a3b7d808e632034 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_024f19c2198d2599f8a7eec5e12f74cd http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7ebea21b94f249c8937a6ff5fedba806 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c22b67fc62a0eebdcb4dc64020e8147e
bibliographicCitation	Lotfipour S, Arnold MM, Hogenkamp DJ, Gee KW, Belluzzi JD, Leslie FM. The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition. Neuropharmacology. 2011 Jul;61(1-2):95–104. doi: 10.1016/j.neuropharm.2011.03.007.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b8439dc1088f5ed8a8d0243217c9ec7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_edbe0c939aeaaa98d1dfe88bb4f4090d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f29e4c9031f34e5ae9b01fedb6056a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3dceb9e982587d30bc69124888c1f95d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0b9bcfba36dfe98200bdbf5b02f1acd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_591845d53b726429b22968f90c7d1b77
date	201107
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC3105177 https://doi.org/10.1016/j.neuropharm.2011.03.007 https://pubmed.ncbi.nlm.nih.gov/21419142
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6077 https://portal.issn.org/resource/ISSN/0028-3908
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition
discusses	http://id.nlm.nih.gov/mesh/M0014029 http://id.nlm.nih.gov/mesh/M0021846 http://id.nlm.nih.gov/mesh/M0014836 http://id.nlm.nih.gov/mesh/M0014026 http://id.nlm.nih.gov/mesh/M0019683 http://id.nlm.nih.gov/mesh/M0006756
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016739Q000139 http://id.nlm.nih.gov/mesh/D016739Q000378 http://id.nlm.nih.gov/mesh/D008996Q000633 http://id.nlm.nih.gov/mesh/D009538Q000008 http://id.nlm.nih.gov/mesh/D014191Q000633
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004298Q000378 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D008995Q000378 http://id.nlm.nih.gov/mesh/D017207 http://id.nlm.nih.gov/mesh/D001921Q000187 http://id.nlm.nih.gov/mesh/D001921Q000378 http://id.nlm.nih.gov/mesh/D012646 http://id.nlm.nih.gov/mesh/D012701Q000378 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D051381
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.4.3.4 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26070 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441233 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5530 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19493

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129095671 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127394659 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129544235 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129261213

Total number of triples: 64.